Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy derived from a clonal population of mature B-lymphocytes characterized by relatively low CD20 antigen expression. Although the disease often takes an indolent course, the majority of patients will eventually require therapy. Standard tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Brian T, Kalaycio, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562745/
https://www.ncbi.nlm.nih.gov/pubmed/26366093
http://dx.doi.org/10.2147/OTT.S68770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562745/
https://www.ncbi.nlm.nih.gov/pubmed/26366093
http://dx.doi.org/10.2147/OTT.S68770

Ejemplares similares